Cardioembolic vs. Noncardioembolic Strokes in Atrial Fibrillation: Frequency and Effect of Antithrombotic Agents in the Stroke Prevention in Atrial Fibrillation Studies

Publisher： Karger

E-ISSN： 1421-9786|10|1|39-43

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.10, Iss.1, 2000-01, pp. : 39-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of Stroke in Patients with Atrial Fibrillation: The Role of New Antiarrhythmic and Antithrombotic Drugs

By  

Cerebrovascular Diseases, Vol. 30, Iss. 3, 2010-07 ,pp. : 314-322

Karger

Access to resources Recommend Favorite

Brain Natriuretic Peptide as a Surrogate Marker for Cardioembolic Stroke with Paroxysmal Atrial Fibrillation

By  

Cerebrovascular Diseases, Vol. 26, Iss. 4, 2008-09 ,pp. : 434-440

Karger

Access to resources Recommend Favorite

Stroke Prevention in Atrial Fibrillation: Concepts and Controversies

By  

Current Cardiology Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 290-301

Bentham Science Publishers

Access to resources Recommend Favorite

Lessons from the stroke prevention in atrial fibrillation trials

By Hart R.G.   Halperin J.L.   Pearce L.A.   for the Stroke Prevention in Atrial Fibrillation Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 67-67

Elsevier

Access to resources Recommend Favorite

New Frontiers for Stroke Prevention in Atrial Fibrillation

By  

Cerebrovascular Diseases, Vol. 33, Iss. 3, 2012-01 ,pp. : 199-208

Karger

Access to resources Recommend Favorite